100 related articles for article (PubMed ID: 31879587)
1. A case of CNS aspergillosis in a patient with chronic lymphocytic leukemia on first-line ibrutinib therapy.
Eichenberger EM; Saullo J; Brander D; Wang SH; Perfect JR; Messina JA
Med Mycol Case Rep; 2020 Mar; 27():17-21. PubMed ID: 31879587
[TBL] [Abstract][Full Text] [Related]
2. Isolated central nervous system Aspergillosis infection in a chronic lymphocytic leukemia patient on Ibrutinib: A case report.
Le TH; Kumar V; Gondal K; Barnes M; Siddique H; Buttar B; Kaell A
BMC Infect Dis; 2020 Feb; 20(1):175. PubMed ID: 32093604
[TBL] [Abstract][Full Text] [Related]
3. Multi-fungal sepsis and mucormycosis of the central nervous system in a patient treated with ibrutinib, a case report and review of the literature.
Fehr M; Cathomas G; Graber A; Makert E; Gaus E; Boggian K
Med Mycol Case Rep; 2020 Mar; 27():14-16. PubMed ID: 31890489
[TBL] [Abstract][Full Text] [Related]
4. Invasive aspergillosis related to ibrutinib therapy for chronic lymphocytic leukemia.
Arthurs B; Wunderle K; Hsu M; Kim S
Respir Med Case Rep; 2017; 21():27-29. PubMed ID: 28377877
[TBL] [Abstract][Full Text] [Related]
5. Invasive Fungal Infection Complicating Treatment With Ibrutinib.
Rajapakse P; Gupta M; Hall R
Cureus; 2021 Jun; 13(6):e16009. PubMed ID: 34336499
[TBL] [Abstract][Full Text] [Related]
6. Cerebral aspergillosis and facial acneiform lesions following initiation of ibrutinib in a patient with chronic lymphocytic leukemia.
Bedier H; Lin J; Frenette C; Routy JP
IDCases; 2021; 26():e01263. PubMed ID: 34504767
[TBL] [Abstract][Full Text] [Related]
7. Amebic Encephalitis in a Patient with Chronic Lymphocytic Leukemia on Ibrutinib Therapy.
Voshtina E; Huang H; Raj R; Atallah E
Case Rep Hematol; 2018; 2018():6514604. PubMed ID: 30155323
[TBL] [Abstract][Full Text] [Related]
8. Incidence and associated risk factors for invasive fungal infections and other serious infections in patients on ibrutinib.
Holowka T; Cheung H; Malinis M; Gan G; Deng Y; Perreault S; Isufi I; Azar MM
J Infect Chemother; 2021 Dec; 27(12):1700-1705. PubMed ID: 34389223
[TBL] [Abstract][Full Text] [Related]
9. Non-Aspergillus invasive mould infections in patients treated with ibrutinib.
Anastasopoulou A; DiPippo AJ; Kontoyiannis DP
Mycoses; 2020 Aug; 63(8):787-793. PubMed ID: 32458510
[TBL] [Abstract][Full Text] [Related]
10. Ibrutinib induces multiple functional defects in the neutrophil response against
Blez D; Blaize M; Soussain C; Boissonnas A; Meghraoui-Kheddar A; Menezes N; Portalier A; Combadière C; Leblond V; Ghez D; Fekkar A
Haematologica; 2020; 105(2):478-489. PubMed ID: 31171644
[TBL] [Abstract][Full Text] [Related]
11. A Rare Instance of Simultaneous Infection with Disseminated Nocardia and Pulmonary Aspergillus in a Patient Receiving Treatment with Ibrutinib for Chronic Lymphocytic Leukemia.
Dotson J; Katz H; Jafri H; Jamil MO; Willenburg KS
Cureus; 2018 Oct; 10(10):e3427. PubMed ID: 30542637
[TBL] [Abstract][Full Text] [Related]
12. Cranial aspergillosis in a patient receiving ibrutinib for chronic lymphocytic leukemia.
Beresford R; Dolot V; Foo H
Med Mycol Case Rep; 2019 Jun; 24():27-29. PubMed ID: 30899641
[TBL] [Abstract][Full Text] [Related]
13. Refractory Chronic Lymphocytic Leukemia with Central Nervous System Involvement: A Case Report with Literature Review.
Nakanishi T; Ito T; Fujita S; Satake A; Konishi A; Hotta M; Yoshimura H; Nomura S
J Blood Med; 2020; 11():487-502. PubMed ID: 33380856
[TBL] [Abstract][Full Text] [Related]
14. Ibrutinib-associated cutaneous mucormycosis due to an
Nguyen TM; Amenta E; Chapman L; Yellapragada S; Krishnan B; Lim J; Hamill RJ
Ther Adv Infect Dis; 2024; 11():20499361241241199. PubMed ID: 38545450
[TBL] [Abstract][Full Text] [Related]
15. HSV-1 Encephalitis in an Elderly Man Receiving Ibrutinib for Waldenstrom's Macroglobulinemia.
Wallace MR
Case Rep Infect Dis; 2020; 2020():6516037. PubMed ID: 32274227
[TBL] [Abstract][Full Text] [Related]
16. [Elderly chronic lymphocytic leukemia combined with invasive aspergillosis infection in one case].
Li BL; Li SX; Wang TM; Zhu HL; Wang HT; Li J; Liu Y; Zhai B
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Feb; 23(1):99-105. PubMed ID: 25687054
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic and pharmacodynamic evaluation of ibrutinib for the treatment of chronic lymphocytic leukemia: rationale for lower doses.
Bose P; Gandhi VV; Keating MJ
Expert Opin Drug Metab Toxicol; 2016 Nov; 12(11):1381-1392. PubMed ID: 27686109
[TBL] [Abstract][Full Text] [Related]
18. Unusual Relapse of Chronic Lymphocytic Leukemia After Remission.
Rizvi W; Truong Q
Cureus; 2018 Feb; 10(2):e2176. PubMed ID: 29651369
[TBL] [Abstract][Full Text] [Related]
19. CNS Aspergillosis and Cryptococcosis with Cytomegalovirus Pneumonia in a Patient with Chronic Lymphocytic Leukemia Treated with Acalabrutinib.
Fallin T; Thacker E; Sahra S; Siegrist EA; White BP; Summers K; Shibib D; Sassine J
J Pharm Pract; 2024 Apr; ():8971900241247660. PubMed ID: 38621678
[TBL] [Abstract][Full Text] [Related]
20. Cytomegalovirus Proctitis in a Patient with Chronic Lymphocytic Leukemia on Ibrutinib Therapy: A Case Report.
Reddy Y; Baig M; Kalva N; Puli S; Dhillon S
Cureus; 2020 Apr; 12(4):e7837. PubMed ID: 32467812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
